MF
MRNA icon

Magnetar Financial’s Moderna MRNA Stock Holding History

Magnetar Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,587
Closed -$532K – 1121
2025
Q3 		$532K Buy
20,587
+13,127
+176% +$366K ﹤0.01% 577
2025
Q2 		$206K Buy
+7,460
New +$196K ﹤0.01% 794
2022
Q4 		– Sell
-1,750
Closed -$207K – 883
2022
Q3 		$207K Buy
+1,750
New +$266K ﹤0.01% 918
2021
Q4 		– Sell
-1,741
Closed -$670K – 1488
2021
Q3 		$670K Buy
+1,741
New +$642K 0.01% 829
2021
Q2 		– Sell
-3,038
Closed -$398K – 1311
2021
Q1 		$398K Buy
3,038
+250
+9% +$36.2K ﹤0.01% 872
2020
Q4 		$291K Sell
2,788
-3,504
-56% -$354K ﹤0.01% 629
2020
Q3 		$445K Buy
+6,292
New +$439K 0.01% 466
2019
Q1 		– Sell
-50,000
Closed -$764K – 450
2018
Q4 		$764K Buy
+50,000
New +$822K 0.02% 131

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Magnetar Financial's MRNA Position: Q4 2025 in Review

Magnetar Financial sold out of Moderna (MRNA) in Q4 2025, closing a stake of 20,587 shares — an estimated $532K sold.

Magnetar Financial first reported a position in MRNA in Q4 2018 and held it in 8 quarters. The position peaked at $764K in Q4 2018. 675 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Magnetar Financial reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Magnetar Financial sold 20,587 Moderna shares in Q4 2025, an estimated $532K.
  • Magnetar Financial first reported a position in Moderna in Q4 2018 and held it in 8 quarters.
  • Magnetar Financial's Moderna position peaked at $764K in Q4 2018.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Magnetar Financial's 13F filing for Q4 2025, filed 17 Feb 2026.